Elpiscience is a clinical-stage biopharmaceutical company dedicated to developing life-changing immuno-oncology therapies for cancer patients worldwide. The company’s innovative approach is focused on removing immunosuppressive factors in the tumor microenvironment, by targeting the adenosine pathway and myeloid checkpoints. A pipeline of novel molecules has been developed using its proprietary platforms including a powerful Bispecific Macrophage Engager (BiME®) technology that connects and activates macrophages for solid tumor killing without causing cytokine storms.
| Website | http://www.elpiscience.com/ |
| Revenue | $21.1 million |
| Employees | 34 (26 on RocketReach) |
| Founded | 2017 |
| Phone | +86 21 5065 1310 |
| Industry | Biotechnology Research, Biopharma, Pharmaceuticals, Biotechnology, Health Care, Science and Engineering, Pharmaceutical |
| Keywords | Immuno-Oncology, Cancer Therapies, Cancer Treatment, Biopharmaceutical, Immunotherapy, Clinical Stage, Oncology, Cancer Research, Drug Development, Biotechnology, Clinical Trials, Pharmaceutical Research, Tumor Microenvironment, Targeted Therapies, Novel Therapies, Precision Medicine, Therapeutic Antibodies |
| Competitors | Roche, Novartis, AbbVie, Merck & Co., Inc., Pfizer, Sanofi, Bristol Myers Squibb, Genentech, Amgen, Lilly India +43 more (view full list) |
Looking for a particular Elpiscience employee's phone or email?
Elpiscience Questions
The Elpiscience annual revenue was $21.1 million in 2026.
Darren Ji is the Chairman and CEO of Elpiscience.
26 people are employed at Elpiscience.
Elpiscience is based in Shanghai, Shanghai.
Top Elpiscience Employees
-
Darren Ji
Chairman and CEO at Elpiscience
California, United States35+ -
Yehua Zhu
VP Clinical Development at Elpiscience
Shanghai, CN2 -
Peter Wang
VP of CMC at Elpiscience
Suzhou, CN11 -
1
-
1
Related Companies
